ProCE Banner Activity

Dr. Eric Daar and Dr. Monica Gandhi: Key HIV Studies From CROI 2023


Hear from CCO’s expert faculty members as they present their insights on some of the most clinically relevant new data presented at CROI 2023, including prevention strategies, long-acting therapies, adverse events, second-line therapies, and coinfection.

Released: March 17, 2023

Expiration: March 15, 2024

No longer available for credit.



Eric S. Daar

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California


Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Eric S. Daar, MD: consultant/advisor/speaker: Gilead, GSK, Merck, Theratechnologies, ViiV; researcher: Gilead Sciences, GSK, ViiV.

Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.